USTR 301 report spells out big pharma’s Asian patent concerns

The office of the United States Trade Representative has just released its annual 301 Special Report, a review of the state of intellectual property rights and their enforcement around the world. Although comprehensive in scope, the report makes…

Get unlimited access to all IAM content